SEC filing showed up today:http://www.sec.gov/Archives/edgar/data/1158223/000117266111000433/affy0711.txtReporting persons are holding 7.20% (1.84% in the case of OrbiMed Advisors LLC and 5.36% in the case of OrbiMed Capital LLC).OrbiMed is one of the premier biotech investment companies.
For new shorts here, in addition to Orbimed, there were some very sophisticated Healthcare funds buying in the most recently reported quarter:http://www.nasdaq.com/asp/holdings.asp?symbol=AFFY&symbol=AAPL&selected=AFFY&FormType=InstitutionalNew Positions: 23 6,964,328 Increased Positions: 57 13,275,254 Decreased Positions: 39 4,193,485 Good move to keep your finger on the trigger, just in case these guys know what they're doing.
New funds will be reporting AFFY stakes. Rhumbline added in Q2. Float getting tight...http://www.nasdaq.com/asp/holdings.asp?symbol=AFFY&symbol=AAPL&selected=AFFY&FormType=Institutional
white-shoed, sharp dressed fund:http://www.orbimed.com/team_partners.htm
Affymax has excellent blue chip biotech INSTITUTIONAL investors.